VG Life Sciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of VG Life Sciences generated cash of -$20,343, which is more than the previous year. Cash used in financing activities reached the amount of $20,343 last year.
Cash Flow
| 2013 | -1.03M | 0 | 1.74M |
|---|---|---|---|
| 2014 | -1.90M | 0 | 1.22M |
| 2019 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 |
| 2022 | -25.56K | 0 | 25.56K |
| 2023 | -20.34K | 0 | 20.34K |
VGLS Cash Flow Statement (2013 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 0 | 0 | 0 | 0 | 0 | 713.89K | 6.09K |
Operating activities | |||||||
Net income | -2.53M | 2.11M | -1.24M | -1.45M | -268.43K | -6.18M | -7.41M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 316.59K | 74.65K |
Cash generated by operating activities | -20.34K | -25.56K | 0 | 0 | 0 | -1.90M | -1.03M |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing activities | |||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | -55.42K | -208.24K |
Cash used in financing activities | 20.34K | 25.56K | 0 | 0 | 0 | 1.22M | 1.74M |
Net Change In Cash | 0 | 0 | 0 | 0 | 0 | -679.9K | 707.80K |
Cash at end of period | 0 | 0 | 0 | 0 | 0 | 33.99K | 713.89K |